- Home
- RLMD vs STRO Comparison
RLMD vs STRO Comparison
Compare RLMD & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- STRO
- Stock Information
- Founded
- RLMD 2004
- STRO 2003
- Country
- RLMD United States
- STRO United States
- Employees
- RLMD N/A
- STRO N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RLMD Health Care
- STRO Health Care
- Exchange
- RLMD Nasdaq
- STRO Nasdaq
- Market Cap
- RLMD 66.7M
- STRO 76.5M
- IPO Year
- RLMD N/A
- STRO 2018
- Fundamental
- Price
- RLMD $1.99
- STRO $0.84
- Analyst Decision
- RLMD Hold
- STRO Hold
- Analyst Count
- RLMD 2
- STRO 7
- Target Price
- RLMD $1.00
- STRO $1.97
- AVG Volume (30 Days)
- RLMD 517.7K
- STRO 450.6K
- Earning Date
- RLMD 11-06-2025
- STRO 11-12-2025
- Dividend Yield
- RLMD N/A
- STRO N/A
- EPS Growth
- RLMD N/A
- STRO N/A
- EPS
- RLMD N/A
- STRO N/A
- Revenue
- RLMD N/A
- STRO $104,473,000.00
- Revenue This Year
- RLMD N/A
- STRO $65.48
- Revenue Next Year
- RLMD N/A
- STRO N/A
- P/E Ratio
- RLMD N/A
- STRO N/A
- Revenue Growth
- RLMD N/A
- STRO N/A
- 52 Week Low
- RLMD $0.24
- STRO $0.52
- 52 Week High
- RLMD $3.98
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- RLMD 59.73
- STRO 44.00
- Support Level
- RLMD $1.89
- STRO $0.84
- Resistance Level
- RLMD $2.84
- STRO $0.95
- Average True Range (ATR)
- RLMD 0.28
- STRO 0.06
- MACD
- RLMD 0.01
- STRO -0.00
- Stochastic Oscillator
- RLMD 37.96
- STRO 12.16
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.